AwardedSpainGoods€2,434,682
1ª Prorroga (adelantada) Suministro de NATALIZUMAB jeringa (TYSABRI) y DIROXIMEL FUMARATO cápsula (VUMERITY) de distribución exclusiva con destino al Servicio de Farmacia del Hospital Clínico San Carlos de Madrid
- Published
- Published 27 March 2025
Overview
1ª Prorroga (adelantada) Suministro de NATALIZUMAB jeringa (TYSABRI) y DIROXIMEL FUMARATO cápsula (VUMERITY) de distribución exclusiva con destino al Servicio de Farmacia del Hospital Clínico San Carlos de Madrid
Key details
- Country
- Spain
- Status
- Awarded
- Category
- Goods
- Estimated value
- €2,434,682
- Procedure
- Direct
- Published
- 27 March 2025
Pharmaceutical products
Award outcome
- Awarded value
- €325,570
- Award date
- 26 March 2025
- Contract period
- — → 28 February 2030
- BIOGEN SPAIN S.L.
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
27 March 2025
Contract Award Notice
26 April 2024
Contracting authority
Hospital Clinico San Carlos
Procuring entityMADRID, Spain
Authority website ↗
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.